{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:33:08Z","timestamp":1787239988468,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"John & Pamela Salter Charitable Trust","award":["R202823"],"award-info":[{"award-number":["R202823"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.exppara.2017.05.006","type":"journal-article","created":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T15:00:54Z","timestamp":1495724454000},"page":"45-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Front-line glioblastoma chemotherapeutic temozolomide is toxic to Trypanosoma brucei and potently enhances melarsoprol and eflornithine"],"prefix":"10.1016","volume":"178","author":[{"given":"Dietmar","family":"Steverding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart A.","family":"Rushworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2017.05.006_bib1","series-title":"Handbook of Drugs for Tropical Parasitic Infections","author":"Abdi","year":"1995"},{"key":"10.1016\/j.exppara.2017.05.006_bib2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1634\/theoncologist.5-2-144","article-title":"Temozolomide, a novel alkylating agent with activity in the central nervous system, may improve the treatment of advanced metastatic melanoma","volume":"5","author":"Agarwala","year":"2000","journal-title":"Oncologist"},{"key":"10.1016\/j.exppara.2017.05.006_bib3","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/j.1460-2075.1985.tb03772.x","article-title":"Cultivation in a semi-defined medium of animal infective forms of Trypanosoma brucei, T. equiperdum, T. evansi, T. rhodesiense and T.\u00a0gambiense","volume":"4","author":"Baltz","year":"1985","journal-title":"EMBO J."},{"key":"10.1016\/j.exppara.2017.05.006_bib4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1517\/17460441.3.2.173","article-title":"Recent initiatives and strategies to developing new drugs for tropical parasitic diseases","volume":"3","author":"Caffrey","year":"2008","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.exppara.2017.05.006_bib5","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.exppara.2017.05.006_bib6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/270347a0","article-title":"Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture","volume":"270","author":"Collins","year":"1977","journal-title":"Nature"},{"issue":"Suppl.\u00a0l","key":"10.1016\/j.exppara.2017.05.006_bib7","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1017\/S0031182097001182","article-title":"The current status of antiparasitic chemotherapy","volume":"114","author":"Croft","year":"1997","journal-title":"Parasitology"},{"key":"10.1016\/j.exppara.2017.05.006_bib8","doi-asserted-by":"crossref","first-page":"9045","DOI":"10.1021\/bi00197a003","article-title":"NMR and molecular modelling investigations of the mechanism of activation of the antitumor drug temozolomide and its interaction with DNA","volume":"33","author":"Denny","year":"1994","journal-title":"Biochemsitry"},{"key":"10.1016\/j.exppara.2017.05.006_bib9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.actatropica.2005.01.005","article-title":"Anti-trypanosomal activity of DNA topoisomerase inhibitors","volume":"93","author":"Deterding","year":"2005","journal-title":"Acta Trop."},{"key":"10.1016\/j.exppara.2017.05.006_bib10","author":"DND"},{"key":"10.1016\/j.exppara.2017.05.006_bib11","first-page":"3367","article-title":"Effect of O6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents","volume":"51","author":"Dolan","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.exppara.2017.05.006_bib12","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1128\/AAC.47.10.3368-3370.2003","article-title":"Activity of megazol, a trypanocidal nitroimidazole, is associated with DNA damage","volume":"47","author":"Enanga","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2017.05.006_bib13","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.pt.2003.09.002","article-title":"Chemotherapy of human African trypanosomiasis: current and future prospects","volume":"19","author":"Fairlamb","year":"2003","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.exppara.2017.05.006_bib14","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1128\/AAC.48.11.4097-4102.2004","article-title":"Modified fixed-ratio isobologram method for studying in\u00a0vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum","volume":"48","author":"Fivelman","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2017.05.006_bib15","doi-asserted-by":"crossref","first-page":"9243","DOI":"10.1158\/0008-5472.CAN-10-1250","article-title":"MGMT-independent temozolomide resistance in pediatric glioblastoma cells associated with a PI3-kinase-mediated HOX\/stem cell gene signature","volume":"70","author":"Gaspar","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.exppara.2017.05.006_bib16","first-page":"1957","article-title":"p53 effects both the duration of G2\/M arrest and the fate of temozolomide-treated human glioblastoma cells","volume":"61","author":"Hirose","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.exppara.2017.05.006_bib17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1017\/S0031182000000822","article-title":"In\u00a0vitro cloning of animal-infective bloodstream forms of Trypanosoma brucei","volume":"80","author":"Hirumi","year":"1980","journal-title":"Parasitology"},{"key":"10.1016\/j.exppara.2017.05.006_bib18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0001-706X(93)90083-N","article-title":"A\u00a0comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites","volume":"55","author":"Huber","year":"1993","journal-title":"Acta Trop."},{"key":"10.1016\/j.exppara.2017.05.006_bib19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrm1907","article-title":"The multifaceted mismatch-repair system","volume":"7","author":"Jiricny","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.exppara.2017.05.006_bib20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.molbiopara.2009.08.008","article-title":"Cell-cycle synchronisation of bloodstream forms of Trypanosoma brucei using Vybrant DyeCycle Violet-based sorting","volume":"169","author":"Kabani","year":"2010","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.exppara.2017.05.006_bib21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0001-706X(93)90089-T","article-title":"Current situation of African trypanosomiasis","volume":"54","author":"Kuzoe","year":"1993","journal-title":"Acta Trop."},{"key":"10.1016\/j.exppara.2017.05.006_bib22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11060-016-2056-6","article-title":"The effects of antiepileptic drugs on the growth of glioblastoma cell line","volume":"127","author":"Lee","year":"2016","journal-title":"J.\u00a0Neurooncol"},{"key":"10.1016\/j.exppara.2017.05.006_bib23","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1055\/s-2001-17351","article-title":"In\u00a0vitro effect of alkaloids on bloodstream forms of Trypanosoma brucei and T.\u00a0congolense","volume":"67","author":"Merschjohann","year":"2001","journal-title":"Planta Med."},{"key":"10.1016\/j.exppara.2017.05.006_bib24","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1001\/jama.1967.03120080053007","article-title":"Culture of normal human leukocytes","volume":"199","author":"Moore","year":"1967","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.exppara.2017.05.006_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0305-7372(97)90019-0","article-title":"Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials","volume":"23","author":"Newlands","year":"1997","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.exppara.2017.05.006_bib26","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1046\/j.1432-1327.2000.01606.x","article-title":"Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity","volume":"267","author":"O'Brien","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.exppara.2017.05.006_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.exppara.2017.05.006_bib28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1023\/A:1022592913323","article-title":"Plasma and cerebrospinal fluid pharmacokinetics of intravenous temozolomide in non-human primates","volume":"61","author":"Patel","year":"2003","journal-title":"J.\u00a0Neurooncol"},{"key":"10.1016\/j.exppara.2017.05.006_bib29","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1021\/jm00164a041","article-title":"Methylating agents as trypanocides","volume":"33","author":"Penketh","year":"1990","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.exppara.2017.05.006_bib30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/00034983.1992.11812627","article-title":"Survival of Trypanosoma brucei brucei in cerebrospinal fluid","volume":"86","author":"Pentreath","year":"1992","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.exppara.2017.05.006_bib31","doi-asserted-by":"crossref","first-page":"e0140131","DOI":"10.1371\/journal.pone.0140131","article-title":"Temozolomide resistance in glioblastoma cell lines: implication of MGMT, MMR, P-glycoprotein and CD133 expression","volume":"10","author":"Perazzoli","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.exppara.2017.05.006_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1756-3305-1-3","article-title":"The history of African trypanosomiasis","volume":"1","author":"Steverding","year":"2008","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.exppara.2017.05.006_bib33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1756-3305-3-15","article-title":"The development of drugs for treatment of sleeping sickness: a historical review","volume":"3","author":"Steverding","year":"2010","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.exppara.2017.05.006_bib34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1756-3305-2-29","article-title":"Trypanocidal activity of the proteasome inhibitor and anti-cancer drug bortezomib","volume":"2","author":"Steverding","year":"2009","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.exppara.2017.05.006_bib35","doi-asserted-by":"crossref","first-page":"e1618","DOI":"10.1371\/journal.pntd.0001618","article-title":"Untargeted metabolomics reveals a lack of synergy between nifurtimox and eflornithine against Trypanosoma brucei","volume":"6","author":"Vincent","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.exppara.2017.05.006_bib36","article-title":"Malaria","volume":"vol. 94","author":"WHO","year":"2016"},{"key":"10.1016\/j.exppara.2017.05.006_bib37","article-title":"Trypanosomiasis, Human African (Sleeping Sickness)","volume":"vol. 259","author":"WHO","year":"2017"},{"key":"10.1016\/j.exppara.2017.05.006_bib38","doi-asserted-by":"crossref","first-page":"e720","DOI":"10.1371\/journal.pntd.0000720","article-title":"NECT is next: implementing the new drug combination therapy for Trypanosoma brucei gambiense sleeping sickness","volume":"4","author":"Yun","year":"2010","journal-title":"PLoS Neg. Trop. Dis."}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489417301832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489417301832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T11:06:29Z","timestamp":1617447989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489417301832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":38,"alternative-id":["S0014489417301832"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2017.05.006","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Front-line glioblastoma chemotherapeutic temozolomide is toxic to Trypanosoma brucei and potently enhances melarsoprol and eflornithine","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2017.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}